Pandemic influenza vaccine policy - Considering the early evidence

New England Journal of Medicine

Volumn 361, Issue 25, 2009, Pages

  Neuzil, Kathleen M ^a  

^a PATH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CROSS REACTING ANTIBODY; HEMAGGLUTINATION INHIBITING ANTIBODY; INFLUENZA VACCINE; NEUTRALIZING ANTIBODY;

ANTIBODY TITER; CLINICAL TRIAL; DRUG DOSE COMPARISON; EDITORIAL; GUILLAIN BARRE SYNDROME; HEALTH CARE POLICY; HEMAGGLUTINATION INHIBITION TEST; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INJECTION SITE PAIN; INJECTION SITE REACTION; INJECTION SITE TENDERNESS; MIDDLE AGED; MORBIDITY; PANDEMIC; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SERODIAGNOSIS; SINGLE DRUG DOSE; UNSPECIFIED SIDE EFFECT;

EID: 70350592502     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe0908224     Document Type: Editorial

References (11)

1. Neustadt RE, Fineberg HV. The swine flu affair: decision-making on a slippery disease. (Accessed September 9, 2009, at http://www.iom.edu/?id=65926.)
2. Greenberg ME, Lai MH, Hartel GF, et al. Response after one dose of a monovalent inf luenza A (H1N1) 2009 vaccine - preliminary report. N Engl J Med 2009;361. DOI: 10.1056/NEJMoa0907413.
3. Clark TW, Pareek M, Hoschler K, et al. Trial of inf luenza A (H1N1) 2009 monovalent MF59-adjuvanted vaccine - preliminary report. N Engl J Med 2009;361. DOI: 10.1056/NEJMoa0907650.
4. Treanor J, Keitel W, Belshe R, et al. Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults. Vaccine 2002;20:1099-1105 (Pubitemid 34135945)
5. Engler RJ, Nelson MR, Klote MM, et al. Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses. Arch Intern Med 2008;168:2405-2414
6. Sumaya CV, Gibbs RS. Immunization of pregnant women with influenza A/New Jersey/76 virus vaccine: reactogenicity and immunogenicity in mother and infant. J Infect Dis 1979;140:141-146
7. Fiore AE, Shay DK, Broder K, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009;58(RR-8):1-52. [Erratum, MMWR Recomm Rep 2009;58:896-7.]
8. Surveillance for pediatric deaths associated with 2009 pandemic influenza A (H1N1) virus infection - United States, April-August 2009. MMWR Morb Mortal Wkly Rep 2009;58:941-947
9. Use of influenza A (H1N1) 2009 monovalent vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009;58(RR-10):1-8.
10. Yamada T. Poverty, wealth, and access to pandemic influenza vaccines. N Engl J Med 2009;361:1129-1131
11. Hurwitz ES, Schonberger LB, Nelson DB, Holman RC. Guillain-Barré syndrome and the 1978-1979 influenza vaccine. N Engl J Med 1981;304:1557-1561